Dispersol Technologies, Inc.
DisperSol uses its pharmaceutical processing technology and equipment to develop drug compositions that otherwise can not be processed
- Stage Not Set
- Industry Biotechnology
- Location Austin, TX, USA
- Currency USD
- Website dispersoltech.com
Company Summary
Dispersol is a high growth coompany with a development program to reformulate and manufacture challenging existing drugs. DisperSol is in advanced development of a tamper resistant /abuse deterrent platform for the manufacture of opioid drugs, that are in testing for 7 global pharma companies. The Company also is developing an oncology drug. Company has 3 issued patents and 3 patent applications. Currently expanding 3X capacity by Q4 2014 .
Team
-
Dr Gershon YanivCEO
Former CEO of IntegriCo Composites, experienced entrepreneur with 25 years leading high tech companies. Former Professor Materials at Northwestern.
-
Dave Miller, PhDVP R&D
Dave is the former principal scientist in charge of reformulations and manufacturing for Hoffman, la Roche.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.